title: Delamanid for Extensively Drug-Resistant Tuberculosis.
authors.affiliation: Otsuka Pharmaceutical Development and Commercialization, Rockville, MD rajesh.gupta@otsuka-us.com.
authors.forename: Rajesh
authors.initials: R
authors.lastname: Gupta
authors.forename: Lawrence J
authors.initials: LJ
authors.lastname: Geiter
authors.forename: Charles D
authors.initials: CD
authors.lastname: Wells
authors.forename: Mengqui
authors.initials: M
authors.lastname: Gao
authors.forename: Andra
authors.initials: A
authors.lastname: Cirule
authors.forename: Heping
authors.initials: H
authors.lastname: Xiao
mesh_terms: D000995:Antitubercular Agents / Q000627:therapeutic use*; D054908:Extensively Drug-Resistant Tuberculosis / Q000188:drug therapy*; D006801:Humans; D009169:Mycobacterium tuberculosis / Q000302:isolation & purification; D009593:Nitroimidazoles / Q000627:therapeutic use*; D010080:Oxazoles / Q000627:therapeutic use*; D013183:Sputum / Q000382:microbiology; D016896:Treatment Outcome
chemical_list: D000995:Antitubercular Agents; D009593:Nitroimidazoles; C516022:OPC-67683; D010080:Oxazoles